1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (6210)
  2. Journal Article (5696)
  3. Review (405)
  4. Book Section (186)
  5. Editorial (186)
  6. Research Letter (169)
  7. Guidelines (86)
  8. Conference Paper (65)
  9. Correspondence (58)
  10. Miscellaneous (17)
  11. Book Whole (9)
Groups
  1. Hematologic Malignancies, Division of (13087)
  2. Department of Medicine (13003)
  3. Center for Hematologic Malignancies (10394)
  4. GSK Faculty (4421)
  5. Adult Leukemia (3582)
  6. Bone Marrow Transplant (2776)

More Groups

People
  1. Sergio Giralt (1050)
  2. Miguel-Angel Perales (913)
  3. Ross Levine (774)
  4. Andrew Zelenetz (767)
  5. Martin Tallman (649)
  6. Steven Horwitz (645)

More People

Years
  1. 2025 (203)
  2. 2024 (670)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3371)
  2. Journal of Clinical Oncology (1214)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (328)
  5. Haematologica (289)
  6. Bone Marrow Transplantation (238)

More Publications

Publishers
  1. American Society of Hematology (3638)
  2. Elsevier Inc. (1609)
  3. American Society of Clinical Oncology (1266)
  4. Nature Publishing Group (994)
  5. American Association for Cancer Research (637)
  6. Wiley Blackwell (430)

More Publishers

Results (13087)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • IVAC +/- R for relapsed or refractory B-cell non-Hodgkin lymphomas: Real-world experience in the modern era
    Meeting Abstract

    Buege, M. J.; Dao, P. H.; Drill, E.; LeVoir, A. C.; Pak, T.; Peterson, T. J.; Straus, D. J.
    Blood (2020)

    Fulltext@MSK | Save
  • Five-year follow-up of ibrutinib plus rituximab vs placebo plus rituximab for Waldenström's macroglobulinemia: Final analysis from the randomized phase 3 iNNOVATE™ study
    Meeting Abstract

    Buske, C.; Tedeschi, A.; Trotman, J.; García-Sanz, R.; MacDonald, D.; Leblond, V.; Mahé, B.; Herbaux, C.; Matous, J. V.; Tam, C. S.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Erythroid specificity and safety of globin-encoding lentiviral vectors
    Meeting Abstract

    Cabriolu, A.; Odak, A.; Kogel, F.; Sadelain, M.
    Blood (2020)

    Fulltext@MSK | Save
  • A single-arm, open-label phase 1 study of itacitinib (ITA) with calcineurin inhibitor (CNI)-based interventions for prophylaxis of graft-versus-host disease (GVHD; GRAVITAS-119)
    Meeting Abstract

    Choe, H.; Shah, N. N.; Chevallier, P.; Rubio, M. T.; Schroeder, M. A.; Hardy, N. M.; Stiff, P. J.; Solano, C.; Yakoub-Agha, I.; Gutman, J. A.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Longitudinal molecular profiling in patients with IDH1-mutant newly diagnosed acute myeloid leukemia treated with ivosidenib
    Meeting Abstract

    Choe, S.; Wang, H.; Roboz, G. J.; DiNardo, C. D.; Stein, E. M.; Mims, A. S.; Prince, G. T.; Watts, J. M.; Fan, B.; Nejad, P.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Impact of comorbidities on response outcomes in patients with chronic myeloid leukemia in chronic phase treated with first-line dasatinib versus imatinib: Exploratory post hoc analysis of DASISION
    Meeting Abstract

    Breccia, M.; Mauro, M. J.; Jabbour, E.; Saglio, G.; Jimenez-Velasco, A.; le Coutre, P. D.; DeGutis, I.; Khan, W.; Sy, O.; Swanink, R.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Bosutinib (BOS) versus imatinib for newly diagnosed chronic phase (CP) chronic myeloid leukemia (CML): Final 5-year results from the BFORE trial
    Meeting Abstract

    Brümmendorf, T. H.; Cortes, J. E.; Milojkovic, D.; Gambacorti-Passerini, C.; Clark, R. E.; le Coutre, P. D.; Garcia-Gutiérrez, V.; Chuah, C.; Kota, V.; Lipton, J. H.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Influence of aging processes on the biology and outcome of multiple myeloma
    Meeting Abstract

    Boyle, E. M.; Williams, L.; Blaney, P.; Ashby, C.; Bauer, M. A.; Walker, B. A.; Choi, J.; Caro, J.; Razzo, B.; Arbini, A. A.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Mosunetuzumab shows promising efficacy in patients with multiply relapsed follicular lymphoma: Updated clinical experience from a phase I dose-escalation trial
    Meeting Abstract

    Assouline, S. E.; Kim, W. S.; Sehn, L. H.; Schuster, S. J.; Cheah, C. Y.; Nastoupil, L. J.; Shadman, M.; Yoon, S. S.; Matasar, M. J.; Diefenbach, C.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Trial in progress: A phase I trial of BTX-A51 in patients with relapsed or refractory AML or high-risk MDS
    Meeting Abstract

    Ball, B. J.; Stein, A. S.; Borthakur, G.; Murray, C.; Kook, K.; Chan, K. W.; Stein, E. M.
    Blood (2020)

    Fulltext@MSK | Save